atorvastatin
Showing 1 - 25 of 462
Cholesterol Variability, Trained Immunity Trial (Atorvastatin)
Not yet recruiting
- Cholesterol Variability
- Trained Immunity
- Atorvastatin
- (no location specified)
Mar 17, 2023
Clinical Stage IIA Cutaneous Melanoma AJCC v8 Trial in Portland (drug, procedure, other)
Not yet recruiting
- Clinical Stage IIA Cutaneous Melanoma AJCC v8
- Atorvastatin
- +4 more
-
Portland, OregonOHSU Knight Cancer Institute
Nov 27, 2023
Overweight Subjects, Obese Subjects Trial in Beijing (metformin, digoxin, IBI362)
Not yet recruiting
- Overweight Subjects
- Obese Subjects
- metformin
- +4 more
-
Beijing, Beijing, ChinaAerospace Center Hospital
Apr 4, 2023
Dyslipidemias, Atherosclerotic Cardiovascular Disease Trial in Seoul (Pitavastatin, Pitavastatin plus Ezetemibe, Atorvastatin)
Not yet recruiting
- Dyslipidemias
- Atherosclerotic Cardiovascular Disease
- Pitavastatin
- +2 more
-
Seoul, Korea, Republic ofYonsei University Health System, Severance Hospital
Jan 29, 2023
Male Erectile Disorder, Prostate Adenocarcinoma, Erectile Dysfunction, CTCAE Trial in Houston (Atorvastatin, Pentoxifylline,
Completed
- Male Erectile Disorder
- +3 more
- Atorvastatin
- +2 more
-
Houston, TexasM D Anderson Cancer Center
Nov 21, 2022
Alagille Syndrome, Atorvastatin, Xanthoma Trial in Shanghai (atorvastatin)
Recruiting
- Alagille Syndrome
- +2 more
- atorvastatin
-
Shanghai, Shanghai, ChinaChildren's Hospital of Fudan University
Aug 3, 2022
Intracerebral Hemorrhage Trial in Szczecin (Atorvastatin, Rosuvastatin, No drugs)
Completed
- Intracerebral Hemorrhage
- Atorvastatin
- +2 more
-
Szczecin, West Pomeranian, PolandPomeranian Medical University
Oct 16, 2023
Breast Cancer, Breast Tumors, Cancer of Breast Trial in New York (Metformin, Atorvastatin, Breast surgery)
Active, not recruiting
- Breast Cancer
- +2 more
- Metformin
- +2 more
-
New York, New YorkColumbia University Medical Center - Herbert Irving Cancer Cente
Aug 16, 2022
Hearing Loss, Head Neck Cancer Trial run by the National Institute on Deafness and Other Communication Disorders (NIDCD)
Not yet recruiting
- Hearing Loss
- Head and Neck Cancer
- Atorvastatin
- Placebo
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Aug 24, 2022
Independent Living, Disability Free Survival, Elderly Trial in Australia (Atorvastatin, Placebo (for Atorvastatin))
Recruiting
- Independent Living
- +3 more
- Atorvastatin
- Placebo (for Atorvastatin)
-
Hobart, Tasmania, Australia
- +5 more
Nov 28, 2022
Cerebral Cavernous Malformation Trial in Chicago (Atorvastatin, Placebo)
Active, not recruiting
- Cerebral Cavernous Malformation
- Atorvastatin
- Placebo
-
Chicago, IllinoisUniversity of Chicago
Jul 26, 2022
Vaccine Response Trial in Atlanta (Atorvastatin, Quadrivalent seasonal influenza vaccine)
Not yet recruiting
- Vaccine Response
- Atorvastatin
- Quadrivalent seasonal influenza vaccine
-
Atlanta, GeorgiaHope Clinic
Aug 29, 2023
Abortion Early Trial in Salt Lake City (Atorvastatin, Misoprostol)
Recruiting
- Abortion Early
- Atorvastatin
- Misoprostol
-
Salt Lake City, UtahPlanned Parenthood Association of Utah
Apr 26, 2022
Healthy Adults Trial in Anaheim (PF-06882961, Atorvastatin, Midazolam)
Completed
- Healthy Adults
- PF-06882961
- +3 more
-
Anaheim, CaliforniaAnaheim Clinical Trials, LLC
Jul 21, 2022
Primary Hypercholesterolemia Trial (Ezetimibe, Atorvastatin, Rosuvastatin)
Type 2 Diabetes Trial in Seoul (Irbesartan/atorvastatin fixed dose combination, Irbesartan SR47436, Atorvastatin)
Completed
- Type 2 Diabetes Mellitus
- Irbesartan/atorvastatin fixed dose combination
- +2 more
-
Seoul, Korea, Republic ofKorea
Apr 5, 2022
Hypercholesterolemia, Atherosclerosis Trial (Ezetimibe + Atorvastatin, Atorvastatin)
Completed
- Hypercholesterolemia
- Atherosclerosis
- Ezetimibe + Atorvastatin
- Atorvastatin
- (no location specified)
Feb 7, 2022
Extra Alirocumab in Addition to Statin Therapy in Symptomatic
Recruiting
- Stroke
- Intracranial Atherosclerotic Stenosis
- Alirocumab
- Atorvastatin
-
Nanjing, Jiangsu, Chinathe First affiliated hospital of Nanjing Medical University
Sep 24, 2023
Intracranial Atherosclerosis, Atherosclerotic Plaque, Stenosis Trial in Nanjing (Alirocumab, Atorvastatin)
Not yet recruiting
- Intracranial Atherosclerosis
- +2 more
- Alirocumab
- Atorvastatin
-
Nanjing, Jiangsu, Chinathe First affiliated hospital of Nanjing Medical University
Oct 10, 2023
Coronary Disease Trial in Assiut (Atorvastatin)
Completed
- Coronary Disease
- Atorvastatin
-
Assiut, EgyptAssiut University
Feb 15, 2022